Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An update from Clover Corporation Limited ( (AU:CLV) ) is now available.
Clover Corporation Limited announced a change in the director’s interest, with Fiona Pearse acquiring 62,996 ordinary shares through an on-market purchase, increasing her total holdings to 149,028 shares. This transaction, valued at $40,050, reflects a strategic move by the director, potentially indicating confidence in the company’s future performance and stability, which could positively impact stakeholder perceptions.
The most recent analyst rating on (AU:CLV) stock is a Buy with a A$0.50 price target. To see the full list of analyst forecasts on Clover Corporation Limited stock, see the AU:CLV Stock Forecast page.
More about Clover Corporation Limited
Clover Corporation Limited operates in the health and nutrition industry, focusing on the development and commercialization of innovative ingredients and products. The company is known for its specialty in microencapsulation technology, which enhances the stability and delivery of sensitive ingredients, particularly in the infant formula and nutritional supplement markets.
Average Trading Volume: 153,887
Technical Sentiment Signal: Hold
Current Market Cap: A$108.5M
Find detailed analytics on CLV stock on TipRanks’ Stock Analysis page.